*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Atlanta | Posted: March 12, 2003
Many of the state’s leading cancer researchers will gather at Georgia Tech from March 27-29 to discuss their recent findings in developing new strategies for cancer detection and control.
The three-day symposium, sponsored by Georgia Tech and the Georgia Cancer Coalition, will bring together top researchers in the field from Georgia Tech, Emory University School of Medicine, the University of Georgia, the Medical College of Georgia and the National Cancer Institute, in addition to other speakers from the biotech industry and cancer-related organizations.
The 11th Annual Suddath Symposium and the Second Annual Georgia Cancer Coalition Symposium will be held at the Georgia Centers for Advanced Telecommunications Technology (GCATT) near the Georgia Tech campus in Atlanta. All symposium sessions are open and free to the Georgia Tech community and cancer researchers at any of the Georgia academic institutions, but pre-registration is recommended.
“This is a unique gathering of investigators who represent essentially the entire spectrum of cancer research, from chemistry to molecular biology, to engineering to the clinic,” said symposium chair Alfred Merrill, who is the Smithgall Institute Chair in Molecular Cell Biology at Georgia Tech and chair of the Georgia Tech Cancer Research Council. “Major advances are born at the junctions between fields, and Georgia is fortunate to be able to bring together this wealth of talent from its universities and the broader scientific community.”
Speakers will describe basic mechanisms of cell regulation that are the underpinning of cancer biology, and new technologies for cancer detection, imaging, targeting and control. Topics include cell-signaling pathways in cancer, cancer detection and control, biosensing and bioimaging, and cancer informatics and biocomputing.
Cancer is the second leading cause of death in Georgia, one of the highest cancer rates in the country.
Cancer research at Georgia Tech is conducted across the disciplines among scientists in areas from biology to computing and biomedical engineering to electrical engineering. Georgia Tech and Emory University operate a joint department in biomedical engineering where faculty at both institutions regularly collaborate on cancer research. Tech recently formed the Georgia Tech Cancer Research Council as part of its strategic plan to bolster cancer research and cancer-related academic programs on campus. The Council consists of faculty whose work touches on cancer research.
The Georgia Cancer Coalition is a statewide collaborative effort, funded with $37 million from the tobacco settlement, involving universities, clinics and hospitals in cancer research. The Coalition works to strengthen the collective impact of existing cancer-related programs and create new initiatives that bring early detection, leading-edge treatment, research, prevention and education to Georgians.
The symposium begins Thursday with a 7 p.m. reception in the atrium of the Petit Institute for Bioengineering and Bioscience on the Georgia Tech campus. The Friday and Saturday sessions will be held at GCATT and both begin at 8:15 a.m. The symposium is also an opportunity for students and research associates to present their research, and for those who are not currently applying their expertise to cancer research to find out how they may fit in.
To register online for the symposium, visit www.ibb.gatech.edu.
